SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #3,788CAS 3区Review JournalHybrid

Current Opinion in Hematology

Abbreviation (ISO):CURR OPIN HEMATOL
Country: United States•WoS SCIE Quartile: Q2•Scopus SJR: 1.17•SCImago Rank: #3,788•Identifier (ISSN):1065-6251(Print)/1531-7048(Online)•Articles / Year: 56•Estimated Publication Fee (APC): $3,400 USD
Clarivate IF (2026)Q2
2.9
– 0

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
90

90 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
56articles/year
12.93% Gold OA•4.65% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 2.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.9)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.9)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.1)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.2)
🔵 Computed
20221.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.218)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.284)
🔵 Computed
20201.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.097)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.864)
🔵 Computed
20181.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.821)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

​​​​​​​​Current Opinion in Hematology is an easy-to-digest bimonthly journal covering the most interesting and important advances in the field of hematology. Its hand-picked selection of editors ensure the highest quality selection of unbiased review articles on themes from nine key subject areas, including myeloid biology, Vascular biology, hematopoiesis and erythroid system and its diseases.

Topics Covered (Recognized by AI)
Medicine94.3%Biology86.7%Internal medicine83.1%Genetics73.8%Immunology69.6%Chemistry55.5%Biochemistry52.6%Pathology46%Cell biology43%Surgery38.1%Psychology29.6%Gene29.1%Stem cell28.6%Psychiatry27.5%Cancer research25.4%Intensive care medicine23.2%Disease22.5%Haematopoiesis21.6%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,788Scopus Q1SCImago Profile
Scopus Coverage:1994-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.17

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
113

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,400 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations367
3-Year Documents132
Citable Documents123

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
HEMATOLOGY
JCRSCIE
41/103Q2
HEMATOLOGY
JCISCIE
38/103Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—231
20252.94565
20243.151324
20233.240295
20223.21847425
20213.28461888
20203.097661,593
20192.864771,422
20182.821631,664
2017—882,707
2016—893,745
2015—912,706
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Opinion in Hematology

WoS Q2
1234201820192020202120222023202420252.90
Annual Impact Factor Metric
2025:2.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f6be52c8-78a4-4913-86e6-49ffdbd6174a
Database Updated: 2026-10-01